October 30, 2020 – Abbott (Abbott Park, IL) received the 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip System, a minimally invasive mitral valve repair device.
The award recognizes excellence in scientific innovation that improves the state of humankind. MitraClip was selected from a field of 17 other medical technology nominees.
This is the second year in a row that an Abbott medical device has been awarded the top prize by Prix Galien – Abbott’s FreeStyle Libre 14 day system, a continuous glucose monitoring technology for people with diabetes, received the award for Best Medical Technology in 2019.
The Prix Galien award for MitraClip is one of several recent recognitions for Abbott:
- Abbott’s newest rapid COVID-19 test, BinaxNOW COVID-19 Ag Card, was recognized as a top innovation by the Chicago Innovation Awards and Abbott’s ID NOW COVID-19 rapid molecular test was recognized by ChicagoInno as a 2020 Inno on Fire winner.
- Abbott’s Amplatzer Piccolo Occluder, which treats preemie and newborn babies with an opening in their hearts, received an Edison Award for its human-centered design in prenatal and infant care, and was also recognized in the R&D 100 Awards, which highlights the most prestigious innovations and revolutionary advancements in science and technology.
- Abbott was recognized as Fast Company’s “World Changing Company of the Year” for its Piccolo innovation, its work advancing the careers of underrepresented people in STEM, initiatives to fight malaria around the world, and for the company’s COVID-19 tests.
- Abbott was also named to Fortune’s 2020 “Change the World” list for expanding access to quality primary care and diagnostic testing in Rwanda, and for advancing innovative testing to confront the COVID-19 pandemic.